Rare Disease Advisory Council
The Rare Disease Advisory Council is an advisory body comprised of community advocates, healthcare professionals, scientists, and state leaders that works to educate medical professionals, government agencies, legislators, and the public about rare diseases as an important public health issue and encourage and secure funding for research for the development of new treatments for rare diseases.
Established by Senate Bill 55 from the 152st General Assembly, the council is housed within the Lieutenant Governor’s Office.
The council will:
- Consult with experts on rare diseases to develop policy recommendations to improve patient access to and quality of rare disease specialists, affordable and comprehensive health care coverage.
- Research and make recommendations to state agencies and insurers that provide services to persons with a rare disease.
- Identify priorities related to treatments and services provided to persons with rare diseases in Delaware and develop policy recommendations that include safeguards against discrimination for these populations on such issues.
Advisory Council Meetings
The Rare Disease Advisory Council meets online, and those meetings are open to the public. If you’d like to attend, please see our Public Meeting Calendar for a schedule of upcoming meetings.
Rare Disease Advisory Council Members
Andrew Babb, PharmD
Pharmacist
Rep. Krista Griffith
State Representative
Sen. Nicole Poore
State Senator
Cristine Vogel
Insurance Commissioner’s Office
Dr. Olubusola Ogunlade
Department of Health and Social Services
Zohra Ali-Khan Catts
Academic Research Institution
Stephen Flachek, MD
Physician
Stepanie H. Guarino, MD
Scientific Community
Kelvin H Lee, Ph.D.
Academic Research Institution
Janice Meyer
Member of the Public
Irfan Patel
Member of the Public
David Tam, MD
Hospital Administrator
Karen Gripp, MD
Geneticist
Jonathan Hawayek
Biopharma Administrator